Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 54001 - 54025 of 102031 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
Oxaliplatin	Approved Investigational	ANXA2	302	upregulated	oxaliplatin results in increased expression of ANXA2 mRNA	15q22.2	A22640
Oxaliplatin	Approved Investigational	ARHGDIA	396	upregulated	oxaliplatin results in increased expression of ARHGDIA mRNA	17q25.3	A23409
Oxaliplatin	Approved Investigational	ASNS	440	downregulated	oxaliplatin results in decreased expression of ASNS mRNA	7q21.3	A23409
Oxaliplatin	Approved Investigational	ATP7A	538	upregulated	oxaliplatin results in increased expression of ATP7A mRNA	Xq21.1	A23410
Oxaliplatin	Approved Investigational	ATP7B	540	downregulated	oxaliplatin results in decreased expression of ATP7B mRNA	13q14.3	A23410
Oxaliplatin	Approved Investigational	ATXN7	6314	downregulated	oxaliplatin results in decreased expression of ATXN7 mRNA	3p14.1	A22638
Oxaliplatin	Approved Investigational	AURKA	6790	downregulated	oxaliplatin results in decreased expression of AURKA mRNA	20q13.2	A23409
Oxaliplatin	Approved Investigational	BAX	581	upregulated	oxaliplatin results in increased expression of BAX mRNA	19q13.33	A22434
Oxaliplatin	Approved Investigational	BCL2	596	downregulated	oxaliplatin results in decreased expression of BCL2 mRNA	18q21.33	A22434
Oxaliplatin	Approved Investigational	BDH2	56898	upregulated	oxaliplatin results in increased expression of BDH2 mRNA	4q24	A22638
Oxaliplatin	Approved Investigational	BIRC5	332	downregulated	oxaliplatin results in decreased expression of BIRC5 mRNA	17q25.3	A23411
Oxaliplatin	Approved Investigational	BNIP3	664	downregulated	oxaliplatin results in decreased expression of BNIP3 mRNA	10q26.3	A23409
Oxaliplatin	Approved Investigational	CA9	768	downregulated	oxaliplatin results in decreased expression of CA9 mRNA	9p13.3	A23409
Oxaliplatin	Approved Investigational	CALB2	794	upregulated	oxaliplatin results in increased expression of CALB2 mRNA	16q22.2	A22638
Oxaliplatin	Approved Investigational	CCS	9973	upregulated	oxaliplatin results in increased expression of CCS mRNA	11q13.2	A23410
Oxaliplatin	Approved Investigational	CD24	100133941	upregulated	oxaliplatin results in increased expression of CD24 mRNA	6q21	A22638
Oxaliplatin	Approved Investigational	CDC37	11140	upregulated	oxaliplatin results in increased expression of CDC37 mRNA	19p13.2	A23409
Oxaliplatin	Approved Investigational	CDC42BPB	9578	upregulated	oxaliplatin results in increased expression of CDC42BPB mRNA	14q32.32	A23409
Oxaliplatin	Approved Investigational	CDKN1A	1026	upregulated	oxaliplatin results in increased expression of CDKN1A mRNA	6p21.2	A23412 A22242
Oxaliplatin	Approved Investigational	CNOT3	4849	upregulated	oxaliplatin results in increased expression of CNOT3 mRNA	19q13.42	A23409
Oxaliplatin	Approved Investigational	COL12A1	1303	downregulated	oxaliplatin results in decreased expression of COL12A1 mRNA	6q13-q14.1	A22638
Oxaliplatin	Approved Investigational	COL13A1	1305	downregulated	oxaliplatin results in decreased expression of COL13A1 mRNA	10q22.1	A22638
Oxaliplatin	Approved Investigational	CSTF3	1479	upregulated	oxaliplatin results in increased expression of CSTF3 mRNA	11p13	A23409
Oxaliplatin	Approved Investigational	CXCL12	6387	downregulated	oxaliplatin results in decreased expression of CXCL12 mRNA	10q11.21	A23409
Oxaliplatin	Approved Investigational	DAG1	1605	upregulated	oxaliplatin results in increased expression of DAG1 mRNA	3p21.31	A23409

Displaying entries 54001 - 54025 of 102031 in total

Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability